pH-sensitive binder design with Proton-PottsMPNN
- 1Technical University of Denmark
Abstract
Physiological compartments span a wide pH range, from blood plasma near pH 7.4 through the mildly acidic tumor microenvironment to the acidified endosome and lysosome, and binders whose affinity responds to these differences underpin recycling antibodies, catalytic extracellular degraders and tumor-conditional therapeutics. Such binders are still obtained mainly by combinatorial histidine scanning and display selection, which is laborious and yields few transferable design rules. Recent computational approaches have enabled the design of pH-sensitive binders that engage at physiological pH and release under acidic conditions, by introducing histidines at key positions so that protonation generates electrostatic repulsion, evaluated through physics-based calculations. However, because the design model has no explicit representation of protonation state, it cannot shape the residues around a titratable site to favor one state over the other, leaving pH sensitivity to be screened for rather than specified. Here we present Proton-PottsMPNN, a sequence-design model that explicitly represents the protonated and deprotonated states of histidine, aspartate and glutamate as distinct sequence tokens. Because protonation state is specified rather than inferred, the model redesigns the microenvironment around a titratable residue so that the chosen protonation state is energetically favored over its alternative. Using Proton-PottsMPNN we designed a library of 8,407 de novo PD-L1 candidate binders in which sequence-structure compatibility and protonation state preference were designed jointly under a single energy function, with no structure-prediction filtering applied. The full library was synthesized and displayed on yeast, then screened against PD-L1 across a series of pH values by fluorescence- and magnetic-activated cell sorting, recovering 237 and 288 unique pH-dependent designs respectively. Transition pH values spanned 4.0 to 5.8, and switches were centered on protonated aspartate and glutamate as well as histidine. Recovered designs showed a stronger model preference for their designed protonation state than designs from the same backbone that were not recovered, and this preference was strongest in the designs that required the most acidic conditions to bind. Proton-PottsMPNN therefore designs binders that engage PD-L1 under acidic conditions fully de novo, directly from a specified protonation state.
Related
- Chamaileon: Cross-Context Binder Design with Contextualized Modeling and Mixed Sampling
- RiboBridge: protein-conditioned de novo RNA binder structure design
- Agent-guided epitope excision enables economical de novo binder design
- Design and Validation of New Primers for Specific and Sensitive Real-time PCR Detection and Quantification of Seven Botulinum Encoding Genes (Serotype A-G) of Clostridium botulinum
- UniqSketch: sensitive and resource-efficient strain-level detection in metagenomes
BibTeX
@misc{jacobsen2026phsensitive,
title = {{pH-sensitive binder design with Proton-PottsMPNN}},
author = {C. P. Jacobsen and L. Deweid and F. Birnbaum and L. W. Gormsen and T. Fryer and U. Jagd and A. Hald and M. G. Rasch and T. Jenkins and S. Ovchinnikov},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.30.755438},
url = {https://www.biorxiv.org/content/10.64898/2026.09.30.755438v1},
note = {CC BY-ND},
}
RIS
TY - UNPB
TI - pH-sensitive binder design with Proton-PottsMPNN
AU - C. P. Jacobsen
AU - L. Deweid
AU - F. Birnbaum
AU - L. W. Gormsen
AU - T. Fryer
AU - U. Jagd
AU - A. Hald
AU - M. G. Rasch
AU - T. Jenkins
AU - S. Ovchinnikov
PY - 2026
DA - 2026/09/30
PB - bioRxiv
DO - 10.64898/2026.09.30.755438
UR - https://www.biorxiv.org/content/10.64898/2026.09.30.755438v1
AB - Physiological compartments span a wide pH range, from blood plasma near pH 7.4 through the mildly acidic tumor microenvironment to the acidified endosome and lysosome, and binders whose affinity responds to these differences underpin recycling antibodies, catalytic extracellular degraders and tumor-conditional therapeutics. Such binders are still obtained mainly by combinatorial histidine scanning and display selection, which is laborious and yields few transferable design rules. Recent computational approaches have enabled the design of pH-sensitive binders that engage at physiological pH and release under acidic conditions, by introducing histidines at key positions so that protonation generates electrostatic repulsion, evaluated through physics-based calculations. However, because the design model has no explicit representation of protonation state, it cannot shape the residues around a titratable site to favor one state over the other, leaving pH sensitivity to be screened for rather than specified. Here we present Proton-PottsMPNN, a sequence-design model that explicitly represents the protonated and deprotonated states of histidine, aspartate and glutamate as distinct sequence tokens. Because protonation state is specified rather than inferred, the model redesigns the microenvironment around a titratable residue so that the chosen protonation state is energetically favored over its alternative. Using Proton-PottsMPNN we designed a library of 8,407 de novo PD-L1 candidate binders in which sequence-structure compatibility and protonation state preference were designed jointly under a single energy function, with no structure-prediction filtering applied. The full library was synthesized and displayed on yeast, then screened against PD-L1 across a series of pH values by fluorescence- and magnetic-activated cell sorting, recovering 237 and 288 unique pH-dependent designs respectively. Transition pH values spanned 4.0 to 5.8, and switches were centered on protonated aspartate and glutamate as well as histidine. Recovered designs showed a stronger model preference for their designed protonation state than designs from the same backbone that were not recovered, and this preference was strongest in the designs that required the most acidic conditions to bind. Proton-PottsMPNN therefore designs binders that engage PD-L1 under acidic conditions fully de novo, directly from a specified protonation state.
ER -